The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBakkavor Regulatory News (BAKK)

Share Price Information for Bakkavor (BAKK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 115.00
Bid: 115.00
Ask: 117.00
Change: -2.50 (-2.13%)
Spread: 2.00 (1.739%)
Open: 120.50
High: 120.50
Low: 115.00
Prev. Close: 117.50
BAKK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

15 Jan 2024 07:00

RNS Number : 6059Z
Bakkavor Group PLC
15 January 2024
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are

attached:

Bakkavor Group plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Details of person subject to the notification obligation

Name

The Baupost Group, L.L.C

City and country of registered office (if applicable)

Boston, USA

4. Full name of shareholder(s) (if different from 3.)

Name

BP-PE5, L.L.C

City and country of registered office (if applicable)

Wilmington, USA

5. Date on which the threshold was crossed or reachedvi:

11/01/2024

6. Date on which issuer notified (DD/MM/YYYY):

12/01/2024

7. Total positions of person(s) subject to the notification obligation

% of voting rights

attached to shares (total of 8.A)

% of voting rights through financial

 instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting

situation on the date on which threshold was crossed or reached

0.0%

0.0%

0.0%

0

Position of

previous

notification (if

applicable)

20.9637%

0.0%

20.9637%

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rights

% of voting rights

Direct

 (DTR5.1)

Indirect

 (DTR5.2.1)

Direct

 (DTR5.1)

Indirect

 (DTR5.2.1)

Ordinary shares

GB00BF8J3Z99

0

0.0%

SUBTOTAL 8. A

0

0.0%

8B1: Financial Instruments according to (DTR5.3.1.R(1) (a))

Type of financial instrument

Expirationdate

Exercise/Conversion Period

Number of voting rights that may be acquired if the

instrument is

exercised/

converted.

% of voting rights

SUBTOTAL 8. B 1

8B2: Financial Instruments with similar economic effect according to (DTR5.3.1R(1) (b))

 

Type of financial instrument

Expirationdatex

Exercise/Conversion

Period

Physical or cash

settlement

Number of voting rights

% of voting rights

 

SUBTOTAL 8.B.2

 

 

9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X")

 

Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or

legal entities (please add additional rows as necessary)

X

 

Ultimate

controlling

person

 

 

Name of

controlled

undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial

instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Seth A. Klarman

0.0

0.0

Baupost Group GP, L.L.C.

 

0.0

0.0

The Baupost Group, L.L.C.

 

0.0

0.0

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

 

Place of completion

Boston, USA

Date of completion

12/01/2024

 

 

ENQUIRIES

Institutional investors and analysts:

Ben Waldron, Chief Financial Officer

+44 (0) 20 7908 6114

Annabel Tagoe-Bannerman, Group General Counsel & Company Secretary

+44 (0) 20 7908 6130

 

About Bakkavor

We are the leading provider of fresh prepared food ("FPF") in the UK, and our presence in the US and China positions the Group well in these, high-growth markets. We leverage our consumer insight and scale to provide innovative food that offers quality, choice, convenience, and freshness. Over 18,500 colleagues operate from 44 sites across our three markets supplying a portfolio of over 2,900 products across meals, pizza & bread, salads and desserts to leading grocery retailers in the UK and US, and international food brands in China.

LEI number: 213800COL7AD54YU9949

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLEAPFAFEKLEFA
Date   Source Headline
12th Apr 20247:00 amRNSDirector/PDMR Shareholding
12th Apr 20247:00 amRNSDirector/PDMR Shareholding
2nd Apr 20241:15 pmRNSDirector Declaration
26th Mar 20241:00 pmRNSDirector/PDMR Shareholding
15th Mar 20247:00 amRNSAnnual Report and Accounts 2023 and Notice of AGM
5th Mar 20244:56 pmRNSFinal Dividend for Full Year 2023
5th Mar 20247:00 amRNSFull Year Results 2023
18th Jan 20247:00 amRNSFull Year 2023 Trading Update
15th Jan 20247:17 amRNSMajor Shareholder Change and Directorate Change
15th Jan 20247:00 amRNSHolding(s) in Company
15th Jan 20247:00 amRNSHolding(s) in Company
11th Jan 20243:48 pmRNSHolding(s) in Company
9th Oct 20233:37 pmRNSDirector/PDMR Shareholding
21st Sep 202312:07 pmRNSHolding(s) in Company
6th Sep 20237:00 amRNSHalf-year Report
20th Jul 202310:07 amRNSDirector Declaration
31st May 20233:11 pmRNSResult of AGM
31st May 20237:00 amRNSQ1 2023 Trading Update
23rd May 20237:00 amRNSDirector/PDMR Shareholding
10th May 20235:16 pmRNSDirector/PDMR Shareholding
13th Apr 20239:54 amRNSDirector/PDMR Shareholding
3rd Apr 20234:05 pmRNSDirector/PDMR Shareholding
29th Mar 202311:57 amRNSHolding(s) in Company
17th Mar 20237:00 amRNSAnnual Report and Accounts 2022 and Notice of AGM
8th Mar 20237:00 amRNSFull Year Results 2022
22nd Feb 20234:35 pmRNSPrice Monitoring Extension
19th Jan 20237:00 amRNSFull year 2022 trading update
18th Jan 20236:00 pmRNSRPS Group
16th Dec 20224:40 pmRNSSecond Price Monitoring Extn
16th Dec 20224:35 pmRNSPrice Monitoring Extension
23rd Nov 20227:00 amRNSQ3 2022 trading update
18th Nov 20227:00 amRNSBoard Committee Membership Changes
13th Oct 20224:05 pmRNSDirector/PDMR Shareholding
10th Oct 20224:35 pmRNSPrice Monitoring Extension
29th Sep 20227:00 amRNSDirectorate Change
21st Sep 20224:41 pmRNSSecond Price Monitoring Extn
21st Sep 20224:35 pmRNSPrice Monitoring Extension
12th Sep 20224:36 pmRNSPrice Monitoring Extension
7th Sep 20227:00 amRNSHalf-year Report
22nd Aug 20224:41 pmRNSSecond Price Monitoring Extn
22nd Aug 20224:35 pmRNSPrice Monitoring Extension
9th Aug 20224:36 pmRNSPrice Monitoring Extension
11th Jul 20224:36 pmRNSPrice Monitoring Extension
22nd Jun 20224:36 pmRNSPrice Monitoring Extension
7th Jun 20227:30 amRNSDirector Declaration
30th May 20224:36 pmRNSPrice Monitoring Extension
27th May 20222:03 pmRNSDirector/PDMR Shareholding
25th May 20223:09 pmRNSResult of AGM
25th May 20221:38 pmRNSDirector/PDMR Shareholding
25th May 20227:00 amRNSQ1 2022 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.